CVS to cover Eli Lilly’s anti-obesity pill, reinstate Zepbound later this year

CVS will cover Eli Lilly’s anti-obesity pill next month, reinstate Zepbound later this year, and keep Wegovy access for Caremark members.

Go to News Site